These sequences are composed of short, spaced, positively charged residues, and their identification will make ADAMTS1, like ADAMTS5 (75), amenable to selective targeting by small molecules or biological agents in contexts where excess proteolytic activity may be detrimental such as cancer (18). This evidence concerns the gene ADAMTS1 and cancer.